CDC to Invest $2.1 Billion to Protect Patients and Healthcare Workers

By Paso Robles Press · Tue Sep 21 2021

CDC to Invest $2.1 Billion to Protect Patients and Healthcare Workers

Funding to strengthen and equip state, local, and territorial public health departments

NATIONAL — The Biden-Harris Administration announced a $2.1 billion investment to improve infection prevention and control activities across the U.S. public health and healthcare sectors. The Biden-Harris Administration, working through the Centers for Disease Control and Prevention (CDC), is investing American Rescue Plan funding to strengthen and equip state, local, and territorial public health departments and other partner organizations with the resources needed to better fight infections in U.S. healthcare facilities, including COVID-19 and other known and emerging infectious diseases.

The funding announced today is a commitment that will allow the United States to expand public health and improve the quality of healthcare in our country, including addressing healthcare-related inequities. It will assist healthcare personnel in preventing infections more effectively in healthcare settings, support rapid response to detect and contain infectious organisms, enhance laboratory capacity, and engage in innovation targeted at combating infectious disease threats. Improvements in infection prevention will span the healthcare continuum, including 6,000 hospitals, 15,400 nursing homes, and other long-term care facilities, 7,900 dialysis clinics, and 4,700 ambulatory surgery centers, and will extend to other outpatient settings.

“This funding will dramatically improve the safety and quality of the healthcare delivered in the United States during the pandemic and in the future,” said CDC Director Rochelle P. Walensky, M.D., M.P.H. “Funding will provide significant resources to our public health departments and healthcare systems and opportunities to develop innovative strategies to protect every segment of the U.S. population, especially those disproportionately affected by the pandemic, at a time that they are hit hard.”

Additionally, these investments will help address the rise of healthcare-associated infections, which increased as U.S. hospitals were inundated by COVID-19—reversing national progress seen prior to the pandemic.

Over the next three years, CDC will issue $1.25 billion of the total to 64 state, local, and territorial health departments to support this work. Initial awards totaling $885 million will be made in October 2021 to these jurisdictional health departments. CDC will use the majority of this initial funding in October, $500 million, to support a new force in the fight against COVID-19 to protect our most disproportionately affected population:

The remaining $385 million to be awarded in October 2021 will go to state, local, and territorial health departments to strengthen five critical areas:

In addition to amounts provided to state, local, and territorial health departments, $880 million will be used over several years to support healthcare partners, academic institutions, and other nonprofit partners to develop new prevention interventions and capacities for infection prevention and control training, data collection, and technical assistance.

The COVID-19 pandemic has reinforced the importance of infection prevention and control in health care to keep the U.S. population—especially our most vulnerable people in nursing homes and hospitals—safe and healthy. The year 2020 marked an unprecedented time for healthcare facilities, many of which were faced with extraordinary circumstances of increased patient caseload, staffing challenges, and other operational changes that may have reduced the implementation of normal infection prevention practices. Recent studies have shown substantial increases in healthcare-associated infections during the pandemic in central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), ventilator-associated events (VAEs), and methicillin-resistant Staphylococcus aureus (MRSA) bacteremia. The data show an urgent need to strengthen infection prevention and control capacities and build healthcare resiliency to withstand future pandemics and maintain national prevention progress.

View on Paso Robles Press